Polomar Health Services, Revenue Growth Rates (PMHS), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Polomar Health Services, Inc.  (OTC: PMHS)
 

PMHS's Revenue Growth by Quarter and Year

Polomar Health Services,'s Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PMHS Revenue (in millions $) FY 2027 FY 2026 FY 2025 FY 2024
4th Quarter December -
3rd Quarter September -
2nd Quarter June 1.53
1st Quarter March 1.01
FY 2.54





PMHS Revenue second quarter 2027 Y/Y Growth Comment
Polomar Health Services, Inc. achieved in the second quarter 2027, above Company average Revenue surge of 15187.05% year on year, to $ 1.53 millions.

According to the results reported in the second quarter 2027, Polomar Health Services, Inc. achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Polomar Health Services, Inc.' s Revenue doubling of 15187.05% ranks overall at the positon no. 0 in the second quarter 2027.


PMHS Revenue ( Y/Y Growth %) 2027
 2026 2025 2024
4th Quarter December - 3050 % 0 % -33.33 %
3rd Quarter September - 0 % -50 % -
2nd Quarter June 15187.05 % 0 % - -
1st Quarter March - - - -
FY   - 1200 % 25 % -

Financial Statements
Polomar Health Services,'s second quarter 2027 Revenue $ 1.53 millions PMHS's Income Statement
Polomar Health Services,'s second quarter 2026 Revenue $ 0.01 millions Quarterly PMHS's Income Statement


PMHS Revenue (Quarter on Quarter Growth %)

 2027
 2026 2025 2024
4th Quarter December - 6200 % 100 % 0 %
3rd Quarter September - 0 % 0 % -
2nd Quarter June 51.36 % - 0 % -
1st Quarter March 60.32 % - -50 % -
FY (Year on Year)   - 1200 % 25 % -


Back to PMHS Growth rate Comparisons >> Back to PMHS Growth rate Comparisons >>


Revenue second quarter 2027 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0

Revenue Y/Y Growth Statistics
High Average Low
27694.64 % 5300.36 % -66.91 %
(Jun 30 2026)   (Jun 30 2025)
Revenue second quarter 2027 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Revenue Y/Y Growth Statistics
High Average Low
27694.64 % 5300.36 % -66.91 %
(Jun 30 2026)   (Jun 30 2025)

Revenue by Quarter for the Fiscal Years 2024, 2025, 2026, 2027

Polomar Health Services,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
10094.47 % 821.15 % -100 %
(Dec 31 2025)  


PMHS's II. Quarter Q/Q Revenue Comment
Polomar Health Services, Inc. achieved in the II. Quarter 2027 below company average Revenue jump of 51.36% quarter on quarter, to $ 1.53 millions.

II. Quarter 2027 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the % in the II. Quarter a year ago.

Within Major Pharmaceutical Preparations industry Polomar Health Services, Inc. achieved highest sequential Revenue growth. While Polomar Health Services,'s Revenue growth quarter on quarter, overall rank is 0.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Revenue Q/Q Growth Statistics
High Average Low
10094.47 % 821.15 % -100 %
(Dec 31 2025)  


PMHS's II. Quarter Q/Q Revenue Comment
Polomar Health Services, Inc. achieved in the II. Quarter 2027 below company average Revenue jump of 51.36% quarter on quarter, to $ 1.53 millions.

II. Quarter 2027 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the % in the II. Quarter a year ago.

Within Major Pharmaceutical Preparations industry Polomar Health Services, Inc. achieved highest sequential Revenue growth. While Polomar Health Services,'s Revenue growth quarter on quarter, overall rank is 0.


Polomar Health Services,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 3.17 $ 1.65 $ 0.65 $ 0.04 $ 0.04
Y / Y Revenue Growth (TTM) 7700.5 % 3220.43 % 1003.04 % -32.83 % -39.2 %
Year on Year Revenue Growth Overall Ranking # 13 # 41 # 3639 # 3709 #
Seqeuential Revenue Change (TTM) 92.36 % 154.41 % 1648.74 % -8.85 % -18.12 %
Seq. Revenue Growth (TTM) Overall Ranking # 13 # 41 # 3639 # 3709 #


Cumulative Revenue growth Comment
With 7700.5% annual Revenue growth, Polomar Health Services, Inc. would report a record annual Revenue surge if the fiscal year would end on Jun 30 2026.

Polomar Health Services, Inc. achieved highest trailing twelve month year on year Revenue growth. While Total ranking has impoved so far to 13, from total ranking in previous quarter at 41.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Revenue TTM Y/Y Growth Statistics
High Average Low
7700.5 %
 2370.39 %
-39.2 %
(Jun 30 2026)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0
Cumulative Revenue growth Comment
With 7700.5% annual Revenue growth, Polomar Health Services, Inc. would report a record annual Revenue surge if the fiscal year would end on Jun 30 2026.

Polomar Health Services, Inc. achieved highest trailing twelve month year on year Revenue growth. While Total ranking has impoved so far to 13, from total ranking in previous quarter at 41.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Revenue TTM Y/Y Growth Statistics
High Average Low
7700.5 %
2370.39 %
-39.2 %
(Jun 30 2026)  






Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PMHS's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue surge for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
4d Molecular Therapeutics Inc 25,106.67%$ 25,106.667 millions
Septerna Inc 22,375.63%$ 22,375.630 millions
Vir Biotechnology Inc 19,582.54%$ 19,582.537 millions
Viskase Holdings inc 17,890.22%$ 17,890.220 millions
Meiragtx Holdings Plc8,608.59%$ 8,608.588 millions


About Polomar Health Services, Revenue Growth Rates (PMHS), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Polomar Health Services Inc (CIK 1265521).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-26-038324
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Polomar Health Services Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.